Determinants of mortality in patients with advanced cirrhosis after transjugular intrahepatic portosystemic shunting.

BACKGROUND & AIMS Transjugular intrahepatic portosystemic shunt (TIPS) placement is effective in the treatment of complications of portal hypertension. This study evaluated the predictors of mortality in a group of cirrhotic patients with advanced liver disease after placement of TIPS. METHODS A retrospective analysis of all patients undergoing TIPS placement over a 21/2-year period was undertaken. RESULTS Fifty-six patients had TIPS placement for variceal hemorrhage, 49 for refractory ascites, and 24 for hepatic hydrothorax (total, 129). Of 21 variables available before TIPS placement, variceal hemorrhage requiring emergent TIPS placement (relative risk [RR], 37.5; 95% confidence interval [CI], 5.4-259) and bilirubin concentration > 3.0 mg/dL (RR, 5.4; 95% CI, 1.4-10.2) were independent predictors of 30-day mortality. Variceal hemorrhage requiring emergent TIPS placement (hazard ratio [HR], 5.1, 95% CI, 2. 2-9.1), alanine aminotransferase level > 100 IU/L (HR, 2.5; 95% CI, 1.2-5.5), bilirubin level > 3.0 mg/dL (HR, 2.6; 95% CI, 1.1-4.6), and pre-TIPS encephalopathy unrelated to bleeding (HR, 2.2; 95% CI, 1.2-4.8) independently predicted death during the follow-up period. A model was developed that separated the patients into 3 groups with significantly different survival rates. CONCLUSIONS A clinical index consisting of 4 pre-TIPS variables can reliably predict outcome after TIPS.

[1]  L. Blendis,et al.  Creation of an intrahepatic portosystemic shunt with a Grüntzig balloon catheter. , 1982, Canadian Medical Association journal.

[2]  J. Rabkin,et al.  Outcome of 100 patients after transjugular intrahepatic portosystemic shunt for variceal hemorrhage. , 1997, The American journal of gastroenterology.

[3]  P. Hayes,et al.  Analysis of prognostic variables in the prediction of mortality, shunt failure, variceal rebleeding and encephalopathy following the transjugular intrahepatic portosystemic stent-shunt for variceal haemorrhage. , 1995, Journal of hepatology.

[4]  D. Hunter,et al.  Refractory ascites: midterm results of treatment with a transjugular intrahepatic portosystemic shunt. , 1997, Radiology.

[5]  H. Blum,et al.  Randomised trial of transjugular-intrahepatic-portosystemic shunt versus endoscopy plus propranolol for prevention of variceal rebleeding , 1997, The Lancet.

[6]  A Ochs,et al.  The transjugular intrahepatic portosystemic stent-shunt procedure for variceal bleeding. , 1994, The New England journal of medicine.

[7]  M. Maynar,et al.  Transjugular intrahepatic portosystemic shunt versus sclerotherapy in the elective treatment of variceal hemorrhage. , 1996, Gastroenterology.

[8]  W. Helton,et al.  Critical appraisal of the angiographic portacaval shunt (TIPS). , 1993, American journal of surgery.

[9]  M. Langer,et al.  The transjugular intrahepatic portosystemic stent-shunt procedure for refractory ascites. , 1995, The New England journal of medicine.

[10]  F. Gordon,et al.  The successful treatment of symptomatic, refractory hepatic hydrothorax with transjugular intrahepatic portosystemic shunt , 1997, Hepatology.

[11]  J R Lake,et al.  Creation of transjugular intrahepatic portosystemic shunts with the wallstent endoprosthesis: results in 100 patients. , 1993, Radiology.

[12]  P. Cole,et al.  Transjugular Intrahepatic Portosystemic Shunts Compared with Endoscopic Sclerotherapy for the Prevention of Recurrent Variceal Hemorrhage , 1997, Annals of Internal Medicine.

[13]  B. Sangro,et al.  Transjugular intrahepatic portal‐systemic shunt in the treatment of refractory ascites: Effect on clinical, renal, humoral, and hemodynamic parameters , 1995, Hepatology.

[14]  P. Cole,et al.  The natural history of portal hypertension after transjugular intrahepatic portosystemic shunts. , 1997, Gastroenterology.

[15]  W. Stremmel,et al.  Transjugular intrahepatic portosystemic stent shunt versus sclerotherapy plus propranolol for variceal rebleeding. , 1997, Gastroenterology.

[16]  H. Conn,et al.  Transjugular Intrahepatic Portal‐systemic Shunts: The State of the Art , 1993 .

[17]  M. Kutner,et al.  Measurement of liver and spleen volume by computed tomography. Assessment of reproducibility and changes found following a selective distal splenorenal shunt. , 1981, Radiology.

[18]  J. Galmiche,et al.  Inhibition of acetylcholine induced intestinal motility by interleukin 1 beta in the rat. , 1996, Gut.

[19]  E. Ring,et al.  Multicenter investigation of the role of transjugular intrahepatic portosystemic shunt in management of portal hypertension. , 1995, Radiology.

[20]  E. Olcott,et al.  Endoscopic Sclerotherapy Compared with Percutaneous Transjugular Intrahepatic Portosystemic Shunt after Initial Sclerotherapy in Patients with Acute Variceal Hemorrhage , 1997, Annals of Internal Medicine.

[21]  M. Abecassis,et al.  Transjugular intrahepatic portosystemic shunt: a nonoperative approach to life-threatening variceal bleeding. , 1987, Canadian journal of surgery. Journal canadien de chirurgie.

[22]  E. Ring,et al.  Two-year outcome following transjugular intrahepatic portosystemic shunt for variceal bleeding: results in 90 patients. , 1995, Gastroenterology.

[23]  S. Kaufman,et al.  Transjugular intrahepatic portal systemic shunt for the management of symptomatic cirrhotic hydrothorax. , 1994, The American journal of gastroenterology.

[24]  B. Bacon,et al.  TIPS: THE NEW KID ON THE BLOCK , 2022 .

[25]  P. Cole,et al.  Transjugular intrahepatic portosystemic shunts for patients with active variceal hemorrhage unresponsive to sclerotherapy. , 1996, Gastroenterology.

[26]  W. Hanafee,et al.  Transjugular portal venography and radiologic portacaval shunt: an experimental study. , 1969, Radiology.

[27]  P. Hayes,et al.  Longterm follow up of transjugular intrahepatic portosystemic stent shunt (TIPSS) for the treatment of portal hypertension: results in 130 patients. , 1996, Gut.